Virax Biolabs Group (VRAX) Institutional Ownership → This unknown company solves the biggest issue with AI (From Manward Press) (Ad) Free VRAX Stock Alerts $0.79 +0.04 (+5.31%) (As of 05/15/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Virax Biolabs Group (NASDAQ:VRAX)CurrentInstitutional OwnershipPercentage8.61%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$178.12KNumber ofInstitutional Sellers(last 12 months)0 Get VRAX Insider Trade Alerts Want to know when executives and insiders are buying or selling Virax Biolabs Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Priority GoldThe 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. Virax Biolabs Group Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024Armistice Capital LLC121,999$178K0.0%N/A7.871% (Data available from 1/1/2016 forward) VRAX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VRAX shares? During the previous two years, the following institutional investors and hedge funds held shares of Virax Biolabs Group shares: Armistice Capital LLC ($178K).Learn more on VRAX's institutional investors. What percentage of Virax Biolabs Group stock is owned by institutional investors? 8.61% of Virax Biolabs Group stock is owned by institutional investors. Learn more on VRAX's institutional investor holdings. Which institutional investors have been buying Virax Biolabs Group stock? The following institutional investors have purchased Virax Biolabs Group stock in the last 24 months: Armistice Capital LLC ($122.00K). How much institutional buying is happening at Virax Biolabs Group? Institutional investors have bought a total of 121,999 shares in the last 24 months. This purchase volume represents approximately $178.12K in transactions. Related Companies: Navidea Biopharmaceuticals Institutional Ownership Sunshine Biopharma Institutional Ownership Panbela Therapeutics Institutional Ownership Lucy Scientific Discovery Institutional Ownership Evelo Biosciences Institutional Ownership Bluejay Diagnostics Institutional Ownership TC Biopharm Institutional Ownership Acorda Therapeutics Institutional Ownership NeuBase Therapeutics Institutional Ownership Tivic Health Systems Institutional Ownership This page (NASDAQ:VRAX) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virax Biolabs Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.